IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 306 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $13,971 | -1.6% | 308 | -11.0% | 0.00% | 0.0% |
Q2 2023 | $14,196 | +65.5% | 346 | +44.2% | 0.00% | +100.0% |
Q1 2023 | $8,578 | +97.5% | 240 | +108.7% | 0.00% | 0.0% |
Q4 2022 | $4,344 | -45.7% | 115 | -37.2% | 0.00% | 0.0% |
Q3 2022 | $8,000 | +300.0% | 183 | +221.1% | 0.00% | – |
Q2 2022 | $2,000 | 0.0% | 57 | 0.0% | 0.00% | – |
Q1 2022 | $2,000 | +100.0% | 57 | +185.0% | 0.00% | – |
Q4 2021 | $1,000 | -66.7% | 20 | -80.4% | 0.00% | -100.0% |
Q3 2021 | $3,000 | +200.0% | 102 | +537.5% | 0.00% | – |
Q2 2021 | $1,000 | -50.0% | 16 | -65.2% | 0.00% | – |
Q1 2021 | $2,000 | -33.3% | 46 | 0.0% | 0.00% | -100.0% |
Q4 2020 | $3,000 | – | 46 | – | 0.00% | – |
Q3 2020 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
Q2 2020 | $1,000 | 0.0% | 20 | 0.0% | 0.00% | – |
Q1 2020 | $1,000 | -50.0% | 20 | -54.5% | 0.00% | -100.0% |
Q2 2019 | $2,000 | -33.3% | 44 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $3,000 | +50.0% | 44 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $2,000 | – | 44 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |